OC-0620: Experimental validation of FMISO simulations on tumor xenografts: a question of O2 consumption?  by Wack, L.J. et al.
S300                                                                                                                                         3rd ESTRO Forum 2015 
 
NW457 was assessed by Western blot, flow cytometry, 
caspase activity, colony formation, wound healing, viability, 
and transmigration assays. 
Results: The novel small-molecule HSP90 inhibitor NW457 
interferes with the radioresistant phenotype of human 
glioblastoma cells as it sensitized LN229 and T98G cells 
towards irradiation-induced clonogenic cell death and 
potently induced apoptosis. NW457 provoked destabilization 
of critical regulators of the DNA damage response (ATM, ATR, 
CHK1 and CHK2) and induced activation of caspase-3 with 
subsequent PARP cleavage. Additionally, NW457 
demonstrated potent anti-invasive activities by decreasing 
the inherent migration of LN229 cells as well as inhibiting 
irradiation-induced hypermigration. 
Conclusions: Taken together, our data on HSP90 inhibition as 
a clinically relevant, novel glioblastoma treatment concept 
suggests that the novel small-molecule inhibitor NW457 might 
improve the efficacy of radiotherapy via a dual mechanism 
involving (i) attenuation of radioresistance through induction 
of apoptosis and impairment of the DNA damage response 
and (ii) inhibition of both inherent and radiation-induced 
migration. 
   
 
Proffered Papers: Physics 11: Quantifications of imaging 
for response prediction  
 
 
OC-0620   
Experimental validation of FMISO simulations on tumor 
xenografts: a question of O2 consumption? 
L.J. Wack1, D. Mönnich1, A. Yaromina2, D. Zips3, M. 
Baumann4, D. Thorwarth5 
1University Hospital for Radiation Oncology, Section for 
Biomedical Physics, Tübingen, Germany 
2Oncoray – Center for Radiation Research in Oncology, 
Technische Universität Dresden, Dresden, Germany  
3University Hospital Tübingen, Department of Radiation 
Oncology, Tübingen, Germany  
4University Hospital Carl Gustav Carus, Department of 
Radiation Oncology, Dresden, Germany  
5University Hospital for Radiation Oncology, Section for 
Biomedical Physics, Dresden, Germany  
 
Purpose/Objective: Tumor hypoxia is prognostic for poor 
outcome after radiotherapy (RT). A method for non-invasive 
assessment of hypoxia is positron emission tomography (PET) 
using radiotracers that accumulate in hypoxic tissue volumes. 
However, many factors that impact tracer accumulation are 
not yet fully understood. Here, mathematical simulations 
may help to further investigate hypoxia PET image formation. 
The purpose of this study is to validate a dedicated 
simulation model against experimental data. The model can 
readily be adapted to a variety of conditions, such as 
different human head and neck cancer (HNC) cell lines (CLs). 
Materials and Methods: Immunohistochemically stained 
sections of tumor xenografts were available for nine HNC cell 
lines, providing information on hypoxia (pimonidazole), 
perfusion (Hoechst 33342), and vessel distribution (CD31). 
They were used to generate 2D maps of perfused blood 
vessels, based on which tissue oxygenation and the 
distribution-retention dynamics for the hypoxia PET tracer 
FMISO were mathematically simulated in order to generate 
FMISO distribution patterns four hours post injection. 
The model includes a Michaelis-Menten relation to describe 
the oxygen consumption inside the tissue. M0, representing 
the maximum oxygen consumption, was chosen as parameter 
for CL-specific optimization as this parameter strongly 
influences tracer distribution. Simulations were optimized for 
M0 on each tumor slice to reach optimum correlations 
between FMISO concentration and pimonidazole staining 
intensity. 
Results: After optimization, very high point-to-point 
correlations up to R2 = 0.85 were found for individual tissue 
sections. Experimental pimondazole staining and simulations 
showed good visual agreement, confirming the validity of the 
approach. Mean correlations per CL varied significantly (p2 
ranging from 0.24 to 0.53.  
The derived maximum oxygen consumption rate M0 differed 
significantly (p0 was found to correlate significantly with the 
previously published BrdU labeling index for these CL (p2 




Conclusions: It is technically feasible to simulate FMISO 
distributions that match the pimonidazole retention patterns 
observed in vivo. Good agreement can be obtained for 
multiple CLs by optimizing the individual oxygen consumption 
rate, M0, whose optimum value differed significantly between 
CLs. Optimized M0 correlated with the proliferation marker 
BrdU, but not with TCD50. 
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Purpose/Objective: Tumor physiology predicts response to 
radiotherapy. The aim of this study was to examine and 
correlate tumor vascularity and glucose metabolism based on 
[18F]-FDG uptake and perfusion maps. 
Materials and Methods: 42 patients with head and neck 
cancer (15 patients T1/T2 and 27 T3/T4), who underwent 
[18F]-FDG PET/CT (270 - 410 MBq FDG) examination together 
with simultaneous perfusion CT (CTP) (40 mL of contrast, 1 s 
rotations time with 1 image/s, cine duration 50 s, 80 mA, 100 
kV), were included in the study. A radiation oncologist 
contoured primary tumor (GTVPT) and lymph node metastases 
(GTVLN) in CTP. Using the gradient-based method GTVPET was 
auto-segmented. Perfusion maps were calculated using 
singular value decomposition method with in-house 
developed software. Blood volume (BV), blood flow (BF), 
